지방산으로 유발된 비알코올지방간질환 실험모델에 미치는 生肝湯加味方의 효과
Effects of Saenggantanggami-bang on Nonalcoholic Fatty Liver Disease Model Induced by Fatty Acids
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Objectives : This study was designed to investigate the effects of Saenggantanggami-bang (SG) on nonalcoholic fatty liver disease. Methods : HepG2 cells were used in an in vitro model. HepG2 cells were divided into three groups. The Normal group was incubated with no fatty acid. The Control group was incubated with 1mM palmitic acid to introduce fat overloading. The PA-SG group was incubated with 1mM palmitic acid and various concentrations of Saenggantanggami-bang (SG). Cell viability and cytotoxicity were analyzed by MTT assay and LDH assay. Intracellular triglyceride (TG) levels, reactive oxygen species (ROS) levels, ATP amount, and GST activity were measured. Cell death pattern and protective effect of SG on cell death were studied by DNA fragmentation and caspase-3 intensity (western blot). Results : Compared with the Control group, cell viability of the PA-SG group significantly increased (P<0.01), cytotoxicity of the PA-SG group decreased (P<0.01), and intracellular TG levels and ROS levels of the PA-SG group decreased (P<0.05). In DNA fragmentation assay, necrotic pattern was observed and DNA fragment decreased in the PA-SG group. In western blot, apoptotic pattern was observed, caspase-3 intensity of the PA-SG group was reduced significantly, but there were no significant differences in intracellular ATP amount and GST activity between the control group and the PA-SG group. Conclusion : The results suggest that Saenggantanggami-bang can be a potential candidate for the clinical treatment of nonalcoholic fatty liver disease.
Abstract
Objectives : This study was designed to investigate the effects of Saenggantanggami-bang (SG) on nonalcoholic fatty liver disease. Methods : HepG2 cells were used in an in vitro model. HepG2 cells were divided into three groups. The Normal group was incubated with no fatty acid. The Control group was incubated with 1mM palmitic acid to introduce fat overloading. The PA-SG group was incubated with 1mM palmitic acid and various concentrations of Saenggantanggami-bang (SG). Cell viability and cytotoxicity were analyzed by MTT assay and LDH assay. Intracellular triglyceride (TG) levels, reactive oxygen species (ROS) levels, ATP amount, and GST activity were measured. Cell death pattern and protective effect of SG on cell death were studied by DNA fragmentation and caspase-3 intensity (western blot). Results : Compared with the Control group, cell viability of the PA-SG group significantly increased (P<0.01), cytotoxicity of the PA-SG group decreased (P<0.01), and intracellular TG levels and ROS levels of the PA-SG group decreased (P<0.05). In DNA fragmentation assay, necrotic pattern was observed and DNA fragment decreased in the PA-SG group. In western blot, apoptotic pattern was observed, caspase-3 intensity of the PA-SG group was reduced significantly, but there were no significant differences in intracellular ATP amount and GST activity between the control group and the PA-SG group. Conclusion : The results suggest that Saenggantanggami-bang can be a potential candidate for the clinical treatment of nonalcoholic fatty liver disease.
참고문헌 (43)
- Ludwig J, "Nonalcoholic steatohepatitis : Mayo Clinic experiences with a hitherto unnamed disease", Mayo Clin Proc., 55(7), pp.434~438 (1980)
- Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med., 346, pp.1221~1231 (2002)
- 최수연, "심혈관계 위험인자로서의 비알코올지방간질환; 경동맥 동맥경화와의 상관관계", The Korean Journal of Hepatology, 14(1), pp.77~88 (2008), 대한간학회
- Park SH, "Pathogenesis and management of nonalcoholic steatohepatitis", JKMA, 48, pp.169~178 (2005)
- McCullough AJ, "The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease", Clin Liver Dis, 8, pp.521~533 (2004)
- Adams LA, "Recent concepts in nonalcoholic fatty liver disease", Diabet Med, 22, pp.1129~1133 (2005)
- Marchesini G, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome", Diabetes, 50, pp.1844~1850 (2001)
- Marchesini G, "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", Hepatology, 37, pp.917~923 (2003)
- Feldstein AE, "Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway", Hepatology, 40, pp.185~194 (2004)
- Jeffrey D Browning, "Molecular mediators of hepatic steatosis and liver injury", The Journal of Clinical Investigation, 114(2), pp.147~151 (2004)
- 이동석, "비알코올성 지방간질환에서 지방간염의 진단 및 간섬유화 정도의 예측인자", 대한간학, 9(3), pp.14~20 (2003)
- 김상진, "비알코올성 지방간 환자에서 지방간염의 병리학적 심화도를 예측할 수 있는 임상적 지표들", 대한소화기학회지, 36, pp.782~792 (2000)
- Rallidis LS, "Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study", Atherosclerosis, 174, pp.193~196 (2004)
- 유권, "비알콜성 지방간염", 대한간학회지, 8(1), pp.66~72 (2002)
- 赵和平, "降脂益肝冲剂治療非酒精性脂肪肝炎的實驗硏究", Drug evaluation, 4(2), pp.114~116 (2007)
- 윤경수, "NASH 동물모델에서 인진청간탕과 인진사령산의 효과규명", 대한한방내과학회지, 30(2), pp.410~421 (2009), 대한한방내과학회
- Lee KT, "Effects of TongBiYeum on the Fatty Liver", Korean Journal of Oriental Medicine, 24(4), pp.11~18 (2003)
- 성태수, "천궁의 열수추출액이 고지방식이에 의한 흰쥐의 혈장 중 효소활성과 호르몬 및 간장의 지방축적에 미치는 영향", Korean Journal Food & Nutrition, 7(2), pp.108~113 (1994)
- 최미영, "加味生肝湯이 고지방식이로 유발된 지방간에 미치는 영향", 대한한방내과학회지, 30(2), pp.365~374 (2009), 대한한방내과학회
- 지형준, "대한약전 및 대한약전외 한약규격주해", pp.109~619 (1998), 한국메디칼인덱스사
- J.Sambrook, "Molecular Cloning", pp.60~75 (1989), Cold Spring Harbor Laboratory Press
- Bakon BR, "Nonalcoholic steatohepatitis: an expanded clinical entity", Gastroenterology, 107, pp.1103~1109 (1994)
- Youssef WI, "Steatohepatitis in obese indivisuals", Best Pract Res Clin Gastroenterol, 45, pp.46~52 (2005)
- 吴其恺, "脂炎消煎剂治療非酒精性脂肪肝 63例的臨床觀察", CJ GMTCM, 22(2), pp.34~35 (2007)
- 전국한의과대학 간계내과학 교수, "간계내과학", pp.315~322 (2001), 동양의학연구원
- 이창규, "生肝湯이 CCl₄및 d-galactosamine에 의하여 유발된 흰쥐의 간장해에 미치는 영향", 경희대학교 대학원, ~ (1986)
- 최서형, "生肝湯과 그 분획이 간장보호, 혈소판응집능 및 일반 면역기능에 미치는 영향", 경희대학교 대학원, ~ (1987)
- 류경하, "生肝湯이 고지혈증에 미치는 영향", 경희대학교 대학원, ~ (1988)
- 승현석, "가감생간탕 투여후 호전된 급성 간염 2예", 대한한방내과학회지, 23(2), pp.228~237 (2002), 대한한방내과학회
- 김영철, "중풍을 동반한 초기간경변증 치험 1례", 대한한방내과학회 별책부록, 19(2), pp.21~28 (1999)
- 김동우, "加減生肝湯을 투여한 간암환자에 관한 연구", 대한한의학회지, 12(2), pp.233~249 (1991)
- TAN De-an, "Experimental study of effect of curcumin treatment on rat nonalcoholic fatty liver disease", 重慶醫學, 36(16), pp.1626~1628 (2007)
- 서부일, "고지방 식이로 유도된 비만 흰쥐에 茵蔯, 枳實, 山？가 미치는 영향", 대한본초학회지, 21(3), pp.55~67 (2006), 대한본초학회
- Sun Liwei, "The effect of Danshen on the nonalcoholic fatty liver rats MDA, SOD, TNF, Leptin", J. of Zhejiang Uni. of traditional Chinese Med., 31(6), pp.696~698 (2007)
- Day CP, "Steatohepatitis: a tale of two "hits"?", Gastroenterology, 114, pp.842~845 (1998)
- Maechler P, "Mitochondrial function in normal and diabetic beta-cells", Nature, 414, pp.807~812 (2001)
- St-Pierre J, "Topology of superoxide production from different sites in the mitochondrial electron transport chain", J. Biol chem., 277, pp.44784~44790 (2002)
- Caldwell SH, "Mitochondrial abnormalities in nonalcoholic steatohepatitis", J. Hepatol., 31, pp.430~434 (1999)
- Chen J, "Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal(HNE): role of HNE adduct formation with the enzyme subunits", Biochim Biophys Acta, 1380, pp.336~344 (1998)
- Poli G, "Pathogenesisof liver fibrosis: role of oxidative stress", Mol Aspects Med, 21, pp.49~98 (2000)
- John D. Hayes, "The Glutathione S-Transferase Supergene Family: Regulation of GST and the contribution of the Isoenzymes to Cancer Chemoprotection and Drug Resistance", Clinical Reviews in Biochemistry and Molecular Biology, 30(6), pp.445~600 (1995)
- Srinivas Kothakota, "Caspase-3-Generated Fragment of Gelsolin: Effector of Morphological Change in Apoptosis", Science, 278(10), pp.294~297 (1997)
- Maria Jose Gomez-Lechon, "A human hepatocellular in vitro model to investigate steatosis", Chemico-Biological Interactions, 165, pp.106~116 (2007)